Evidence map›Paper›PMID 26920397›Full record

ReviewIndian journal of pediatrics2016

Hematopoietic Stem Cell Transplantation for Primary Immune Deficiency Disorders.

Neena Kapoor, Revathi Raj

Abstract readReview
PubMed Publisher
In one paragraph

Review in Indian journal of pediatrics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Neena KapoorBlood and Marrow Transplantation Program, Childrens Hospital, Los Angeles, 4650 Sunset Blvd., Los Angeles, CA, 90027, USA.
Revathi RajDepartment of Blood and Marrow Transplantation, Apollo Speciality Hospital, 320 Padma Complex, Anna Salai, Chennai, 600035, India. revaraj@yahoo.com.ORCID http://orcid.org/0000-0003-1415-4142

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hematopoietic stem cell transplantation provides a curative option for children with primary immune deficiency disorders. Increased awareness and rapid diagnosis of these conditions has resulted in early referral and the chance to offer a curative option for affected children. Management of these children involves a multidisciplinary team including infectious disease specialists and intensivists. The use of reduced intensity conditioning chemotherapy, advances in detection and therapy of viral and fungal infections, optimal supportive care and techniques in stem cell processing, including T cell depletion has enabled doctors to transplant children with co-morbid conditions and no matched donors. Transplantation for these children has also brought in deep insights into the world of immunology and infectious diseases.

Indexed as

Immunologic Deficiency SyndromesChildDisease ManagementEarly DiagnosisEarly Medical InterventionHematopoietic Stem Cell TransplantationHumansTransplantation ConditioningBone marrow transplantationHaploidentical stem cell transplantationPrimary immune deficiencyReduced intensity conditioning

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.